MétaCan
Menu
Back to cohort
Record W4403732678 · doi:10.3390/curroncol31110484

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting

2024· article· en· W4403732678 on OpenAlexafffundvenueabout
Mita Manna, Karen A. Gelmon, Jean-François Boileau, Christine Brezden‐Masley, Jeffrey Cao, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, Christine Simmons, Nathaniel Bouganim, Muriel Brackstone, David W. Cescon, Stephen Chia, Ian S. Dayes, Scott Edwards, John Hilton, Anil A. Joy, Kara Laing, Marc Webster, Jan‐Willem Henning

Bibliographic record

VenueCurrent Oncology · 2024
Typearticle
Languageen
FieldMedicine
TopicHER2/EGFR in Cancer Research
Canadian institutionsSt Joseph's Health CarePrincess Margaret Cancer CentreOttawa HospitalJuravinski Cancer CentreMcGill University Health CentreSunnybrook Health Science CentreSaskatchewan Cancer AgencyMount Sinai HospitalDr. H. Bliss Murphy Cancer CentreJewish General Hospital
FundersCanadian Institutes of Health ResearchGenentechAstellas PharmaSeagenIpsenBeiGeneMcGill UniversityHelsinnEisaiPurdue UniversityGilead SciencesDaiichi Sankyo EuropeSanofiAmgenPfizerCelgeneMyriad GeneticsAstraZenecaEli Lilly and CompanyUniversity of TorontoGenomic HealthGlaxoSmithKline
KeywordsMedicineBreast cancerExcellenceMetastatic breast cancerCancerFamily medicineOncologySystemic therapyClinical trialInternal medicine

Abstract

fetched live from OpenAlex

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer is an aggressive subtype of breast cancer associated with a poor prognosis when sub-optimally treated. Recent advances include new and effective targeted therapies that have significantly improved outcomes for patients. Despite these advances, there are significant gaps across Canada, underscoring the need for evidence-based consensus guidance to inform treatment decisions. Addressing these gaps is crucial to ensuring that effective therapies are integrated into clinical practice, so as to improve the lives of patients affected by this aggressive form of breast cancer. The Research Excellence, Active Leadership (REAL) Canadian Breast Cancer Alliance is a standing nucleus committee of clinical-academic oncologists across Canada and Breast Cancer Canada, a patient organization. The mandate of this group is to provide evidence-based guidance on best practices in the management of patients with breast cancer. These consensus recommendations were developed using a modified Delphi process with up to three rounds of anonymous voting. Consensus was defined a priori as ≥75% of voters agreeing with the recommendation as written. There are 9 recommendations in the early setting; 7 recommendations in the metastatic setting; and 10 recommendations for patients with brain metastases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.074
metaresearch head score (Gemma)0.180
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.357
Threshold uncertainty score0.719

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0740.180
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.006
Bibliometrics0.0080.007
Science and technology studies0.0080.004
Scholarly communication0.0070.005
Open science0.0090.007
Research integrity0.0150.012
Insufficient payload (model declined to judge)0.0200.009

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.124
GPT teacher head0.487
Teacher spread0.363 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2024
Admission routes4
Has abstractyes

Explore more

Same venueCurrent OncologySame topicHER2/EGFR in Cancer ResearchFrench-language works237,207